Global Telmisartan Dispersible Tablets Market Size, Share, and Trends Analysis Report, By Product Type (80 mg and 40 mg), By Application (Online Sales and Offline Sales), Forecast (2022-2028) The global telmisartan dispersible tablets market is anticipated to grow at a CAGR of 3.2% during the forecast period. The presence of key players such as Abbott, Bayer AG, Merck & Co., Johnson & Johnson and the rising prevalence of hypertension and chronic kidney diseases globally are some key factors accelerating the market growth. Besides, major industrial advancements such as partnerships, collaboration, and the set-up of R&D facilities are expected to fuel the market growth. For instance, in May 2019, Daiichi Sankyo Company, Ltd. launched MINNEBRO Tablets 1.25 mg, 2.5 mg, and 5 mg (generic name: esaxerenone; hereafter, the drug). The drug was developed by the company in research collaboration with Exelixis, Inc. Marketing approval for the indication of hypertension was received in January 2019. The global telmisartan dispersible tablets market is segmented based on product type and application. Based on product type, the market is segmented into 80 mg and 40 mg. Based on application, the market is segmented into online sales and offline sales. Among these, the offline segment is projected to account for the high share during the forecast period. The high availability of telmisartan dispersible tablets in retail pharmacies and supermarkets is the major factor enhancing the market growth. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific region is expected to grow at the fastest rate during the forecast period. The rising prevalence of hypertension is driving the growth of the market in the region. Whereas the North American region is expected to hold the biggest market share in terms of revenue owing to the easy availability of hypertension drugs such as telmisartan dispersible tablets. The major players in the global telmisartan dispersible tablets market include Abbott Laboratories, Bayer AG, and Pfizer, Inc., among others. The market players are contributing to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. Research Methodology The market study of the global telmisartan dispersible tablets is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports. Secondary Sources Include • Financial reports of companies involved in the market. • Whitepapers, research papers, and news blogs. • Company websites and their product catalog. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models. Market Segmentation 1. Global Telmisartan Dispersible Tablets Research and Analysis by Product Type 2. Global Telmisartan Dispersible Tablets Research and Analysis by Application The Report Covers • Comprehensive research methodology of the global telmisartan dispersible tablets market. • This report also includes a detailed and extensive market overview with key analyst insights. • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. • Analysis of regional regulations and other government policies impacting the global telmisartan dispersible tablets market. • Insights about market determinants that are stimulating the global telmisartan dispersible tablets market. • Detailed and extensive market segments with the regional distribution of forecasted revenues. • Extensive profiles and recent developments of market players.